Table 2.
Primary melanomas N mut/total N (%) | Metastases N mut/total N (%) | Materials | Sub‐dissection | Detection method | References |
---|---|---|---|---|---|
6/9 (67) | P | No | D,G,I | Davies et al., 2002 | |
22/35 (63)a | F | No | D,G,I | Brose et al., 2002 | |
7/28 (25) | 8/13 (62) | P | Yes | D,I | Dong et al., 2003 |
33/77 (43) | F | No | D,I | Gorden et al., 2003 | |
4/5 (80) | 37/55 (67) | P | Yes | D,I | Pollock et al., 2003 |
7/25 (28) | 26/60 (38) | F | No | D,H | Alsina et al., 2003 |
14/25(52) | P | Yes | D,H,I | Uribe et al., 2003 | |
2/10 (20) | 14/34 (41) | P | No | D,G,I | Cruz et al., 2003 |
41/71 (58) | 43/88 (49) | P | Yes | D,F,I | Omholt et al., 2003 |
32/115 | P | No | D,I | Maldonado et al., 2003 | |
12/35 (34) | P | No | D,F,I | Kumar et al., 2003a | |
26/38 (68) | P | No | DF,I | Kumar et al., 2003b | |
19/50 (38) | P | Yes | D,F,I | Deichmann et al., 2004 | |
8/15 (53) | 6/22 (27) | F | No | D,F,I | Reifenberger et al., 2004 |
39/114 (34) | 36/86 (42) | P | Yes | D,I | Houben et al., 2004 |
18/59 (31) | 39/68 (57) | P | Yes | D,I | Shinozaki et al., 2004 |
25/36 (69) | 43/79 (54) | F | No | D,H | Goydos et al., 2005 |
17/37 (46) | P | Yes | D,I | Thomas et al., 2004 | |
9/12 (75) | P | No | D,F,I | Saldanha et al., 2004 | |
15/51 (29)b | 8/18 (44) | P | Yes | D,F,I | Akslen et al., 2005 |
13/52 (25) | P | No | D,G,I | Lang and MacKie, 2005 | |
3/27 (11)c | P | No | D,I | Curtin et al., 2005 | |
22/37 (60)d | |||||
33/58 (57) | P | Yes | D,I | Goel et al., 2006 | |
156/294 (53)e | F | No | D,K | Edlundh‐Rose et al., 2006 | |
8/15 (53) | P | Yes | D,I | Lassacher et al., 2006 | |
17/62 (27) | P | Yes | D,I | Poynter et al., 2006 | |
53/97 (55) | F | No | D,G,I | Ugurel et al., 2007 | |
Total 393/983 (40) | 528/1029 (51) |
Materials: F=fresh frozen tissues; P=formalin fixed, paraffin embedded tissues; manual or laser capture sub‐dissection: yes/no=Detection Method: D PCR or RT PCR; E allele specific oligonucleotide hybridization; F SSCP or DGGE; G HPLC/capillary techniques; H RFLP dependent or allele specific amplification; I nucleotide sequencing; K pyrosequencing.
Early passage melanoma cell lines.
NM only.
Continuously sun exposed sites, mainly LMM.
Intermittently sun exposed sites, mainly SSM.
Including 39 primary melanomas.